PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.40
Bid: 51.70
Ask: 52.00
Change: -1.30 (-2.47%)
Spread: 0.30 (0.58%)
Open: 55.00
High: 55.00
Low: 51.40
Prev. Close: 52.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

Wed, 06th Oct 2021 09:18

(Alliance News) - Shares in IP Group PLC sank on Thursday morning as the company announced a raft of changes to its executive board, triggered by the recent successful float of investee business Oxford Nanopore Technologies Ltd.

Shares in the London-based investor in intellectual property-based businesses were 5.9% lower at 128.80 pence each in London, the worst performer in the FTSE 250 index.

IP Group Chief Executive Alan Aubrey and Chief Investment Officer Mike Townend both will retire from their positions effective immediately.

The news comes after Oxford Nanopore's hugely successful initial public offering on the Main Market of the London Stock Exchange last Thursday, that saw the life sciences business almost reach a GBP5 billion valuation.

The float was a big a win for IP Group, a founding investor in Oxford Nanopore with a 14% stake. The firm made around GBP84 million from the sale of shares but retains a 10% stake in the firm, valued at GBP348.8 million based on the offer price.

Oxford Nanopore was up 1.9% at 578.47p on Wednesday. It had floated at 425p a share last month.

As part of the board reshuffle, IP Group announced that Chief Financial Officer Greg Smith will succeed Aubrey as chief executive, while Chief Operating Officer David Baynes will take on responsibility for finance and become chief financial & operating officer.

"During Alan's tenure as chief executive, the value of the portfolio has increased more than 28-fold to over GBP1.2 billion and has produced several companies worth more than GBP1 billion. We are delighted that Greg will step into the role of chief executive and lead the group in its next phase," commented Chair Douglas Flint.

To help facilitate a handover, both Aubrey and Townend will remain as employees until April 6 and as consultants for a minimum of 12 months from April, IP Group said.

Alan Aubrey said: "Following the successful flotation of Oxford Nanopore Technologies on the London Stock Exchange, this felt a natural moment to step back."

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Nov 2021 14:15

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

Read more
11 Nov 2021 14:57

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

Read more
11 Nov 2021 09:18

IP Group portfolio company inks joint development agreement with Ceres Power

(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company RFC Power, a long-duration energy storage company, had signed a joint development agreement with fuel cell technology firm Ceres Power.

Read more
29 Oct 2021 14:36

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

Read more
25 Oct 2021 16:10

IN BRIEF: IP Group books GBP27.5 million fair value gain

IN BRIEF: IP Group books GBP27.5 million fair value gain

Read more
25 Oct 2021 08:42

IP Group records £27.5m value gain after recent funding round

(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portfolio company in its top 20 most valuable holdings, it recorded a net realised and unrealised fair value gain of about £27.5m, or 2.6p per share.

Read more
19 Oct 2021 10:50

Oxford BioMedica licences technology for cystic fibrosis treatment

Oxford BioMedica licences technology for cystic fibrosis treatment

Read more
19 Oct 2021 09:18

Boehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology

(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.

Read more
12 Oct 2021 14:40

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

Read more
6 Oct 2021 12:11

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

Read more
6 Oct 2021 09:26

IP Group CEO, CIO step down after Oxford Nanopore IPO

(Sharecast News) - IP Group said on Wednesday that chief executive Alan Aubrey and chief investment officer Mike Townend are retiring and stepping down from the board with immediate effect following the successful flotation of its largest holding, Oxford Nanopore Technologies.

Read more
30 Sep 2021 12:11

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

Read more
30 Sep 2021 10:47

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

Read more
30 Sep 2021 10:42

Shares soar as Oxford Nanopore makes its London debut

(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Thursday after the British biotech made its £3.4bn debut on the London Stock Exchange.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.